USPTO serial 79197023
KANGSTEM BIOTECH
Reviewed by CopyMark Law Group
Reg. 5361909Status 709
- Filing date
- Status date
- Registration date
- Dec 26, 2017
- Examiner
- CARROLL, DORITT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KANGSTEM BIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Body lotion; body milk; skin lotions; cosmetic creams for skin care; cosmetic preparations for skin care; skin cream; skin cleansers; eye cream; facial lotions; facial cream; face milk and lotions; face and body lotions; face and body milk; cosmetics for the face and body; lotions for face and body care; face and body creams; lotions for cosmetic purposes; cosmetics; cosmetic skin milk lotions | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations for immunity adjustment; vaccines; cord blood for medical use; allergy medications; Skin lotions for pharmaceutical purposes; ointments for pharmaceutical purposes, namely, antibiotic ointments, anti-inflammatory ointments, anti-itch ointment; chemico-pharmaceutical preparations for the treatment of cancer; pharmaceutical agents for epidermis; microorganism preparation for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; stem cells for medical purposes; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for the treatment of cells; preparations for treatment of cancer; biological preparations for medical and clinical purposes, being extracted from stem cells, stem cell tissues, stem cell tissue scaffolds and the combinations thereof, all for the treatment of cancer; drugs for medical and clinical purposes, being extracted from stem cells, stem cell tissues, stem cell tissue scaffolds and the combinations thereof, all for the treatment of cancer; pharmaceutical preparation for treatment of auto-immune diseases; stem cell medicine; bouillons for stem cultures | SECTION 71 - CANCELLED | — |
| 042 | Cosmetology research; research and development of vaccines and medicines; biotechnology research; advisory services relating to biotechnology; research on cancer; pharmaceutical products development; research on the subject of pharmaceuticals; research in the field of gene analysis; genetic research; research for medical products; medical research; product safety testing; quality control for others; cosmetic research; research services in the field of cosmetics; survey services in the nature of technical consulting regarding pharmaceutical studies in the field of cosmetics; development of cell therapy products; stem cell collection for medical research purposes; stem cell testing for medical research purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kangstem Biotech CO., LTD.
- Other trademarks owned by Kangstem Biotech CO., LTD.
- Other trademarks owned by Kangstem Biotech CO., LTD.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named KANGSTEM BIOTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 20, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 31, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 31, 2025 | INPC | INVALIDATION PROCESSED | — |
| Mar 12, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 12, 2024 | C71T | CANCELLED SECTION 71 | — |
| Nov 7, 2018 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 19, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 30, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 30, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 26, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 26, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 21, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 10, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 4, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 4, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 20, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 5, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Sep 1, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 1, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 1, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 1, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 22, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 10, 2017 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 28, 2017 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 17, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 8, 2017 | ALIE | ASSIGNED TO LIE | — |
| May 12, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 30, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 12, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 12, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 11, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 10, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 2, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |